Multicentre study of 4626 patients assesses the effectiveness, safety and burden of two categories of treatments for central retinal vein occlusion: intravitreal anti-vascular endothelial growth factor injections and intravitreal Ozurdex injections. (2021)
Attributed to:
Centre for Health service and Academic Partnership in Translational eHealth Research (CHAPTER)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1136/bjophthalmol-2020-317306
PubMed Identifier: 32962992
Publication URI: http://europepmc.org/abstract/MED/32962992
Type: Journal Article/Review
Volume: 105
Parent Publication: The British journal of ophthalmology
Issue: 11
ISSN: 0007-1161